ObjectiveTo investigate the potential distribution of radiolabelled botulinum neurotoxin type A (BoNT/A) in the CNS after bladder injection in normal rats, by using the gammaemitting radionuclide technetium-99 m ( 99m Tc).
Materials and MethodsBoNT/A was radiolabelled by pretreatment with 2-iminothiolane and incubation with 99m Tc-gluconate. The labelled toxin 99m Tc-BoNT/A was purified using size exclusion HPLC. Twenty-four female Wistar rats were evenly injected in the bladder wall with either 99m Tc-ΒοΝΤ/Α (n = 12) or free 99m Tc (n = 12). Four rats from each group were killed at 1, 3 and 6 h after injection, respectively. The bladder, L6-S1 spinal cord segment and L6-S1 dorsal root ganglia (DRG) were harvested and their radioactivity counted in a gamma scintillation detector. Results were calculated as % injected dose (I.D.) per gram of tissue. The paired t-test was used for comparison of means of 99m Tc-ΒοΝΤ/Α radioactivity vs free 99m Tc in the tissues of interest.
ResultsRadiolabelled BoNT/A had a high radiochemical stability of 70% after 24 h. Gradual accumulation of 99m Tc-ΒοΝΤ/Α was observed in the DRG up to 6 h after injection (P = 0.04 and P = 0.029 compared with 1 h and 3 h, respectively), while no accumulation was detected for free 99m Tc. Consequently, 99m Tc-ΒοΝΤ/Α radioactivity in the DRG was higher than free 99m Tc radioactivity
ConclusionsSignificant accumulation of the radiolabelled toxin in the lumbosacral DRG, together with a less significant uptake in the respective spinal cord segment as opposed to free radioactivity provide first evidence of the retrograde transport of BoNT/A to the CNS after bladder injection in rats.